Making the case for combination therapies.
Navigating a management dilemma in this young surgeon who had LASIK.
Retina PractiCare tool can show how your claims compare with peers’—and maybe help keep auditors away.
This hydrodissection approach avoids risks of iatrogenic retinal tears and optic nerve
The one-year reprieve ends October 1. Here’s what you can expect and how to prepare.
Co-inventor David Huang, PhD, shares the next big thing for today’s big thing.
Phase II trial shows Clearside’s CLS-TA safe and effective in noninfectious uveitis.